Jeff Yass’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-622,837
| Closed | -$103M | – | 14138 |
|
|
2021
Q2 | $103M | Buy |
+622,837
| New | +$104M | 0.01% | 773 |
|
|
2020
Q4 | – | Sell |
-2,584
| Closed | -$289K | – | 12006 |
|
|
2020
Q3 | $262K | Sell |
2,584
-2,336
| -47% | -$238K | ﹤0.01% | 8976 |
|
|
2020
Q2 | $479K | Sell |
4,920
-6,117
| -55% | -$569K | ﹤0.01% | 7457 |
|
|
2020
Q1 | $917K | Buy |
11,037
+2,338
| +27% | +$228K | ﹤0.01% | 5607 |
|
|
2019
Q4 | $967K | Sell |
8,699
-489
| -5% | -$50.3K | ﹤0.01% | 5610 |
|
|
2019
Q3 | $911K | Sell |
9,188
-21,989
| -71% | -$2.18M | ﹤0.01% | 5878 |
|
|
2019
Q2 | $3.09M | Buy |
31,177
+18,748
| +151% | +$1.79M | ﹤0.01% | 3399 |
|
|
2019
Q1 | $1.37M | Sell |
12,429
-3,787
| -23% | -$396K | ﹤0.01% | 4394 |
|
|
2018
Q4 | $1.49M | Sell |
16,216
-75,729
| -82% | -$7.66M | ﹤0.01% | 3987 |
|
|
2018
Q3 | $10.1M | Buy |
91,945
+77,114
| +520% | +$8.03M | ﹤0.01% | 1917 |
|
|
2018
Q2 | $1.39M | Buy |
14,831
+3,083
| +26% | +$265K | ﹤0.01% | 4698 |
|
|
2018
Q1 | $975K | Sell |
11,748
-28,620
| -71% | -$2.54M | ﹤0.01% | 5293 |
|
|
2017
Q4 | $3.68M | Buy |
40,368
+28,590
| +243% | +$2.38M | ﹤0.01% | 2922 |
|
|
2017
Q3 | $898K | Buy |
+11,778
| New | +$890K | ﹤0.01% | 5469 |
|
|
2017
Q2 | – | Sell |
-32,483
| Closed | -$2.25M | – | 10098 |
|
|
2017
Q1 | $2.12M | Sell |
32,483
-20,176
| -38% | -$1.19M | ﹤0.01% | 3621 |
|
|
2016
Q4 | $2.9M | Buy |
+52,659
| New | +$2.89M | ﹤0.01% | 3311 |
|
|
2016
Q3 | – | Sell |
-25,388
| Closed | -$1.24M | – | 9299 |
|
|
2016
Q2 | $1.06M | Buy |
+25,388
| New | +$1.17M | ﹤0.01% | 4769 |
|
|
2015
Q1 | – | Sell |
-14,905
| Closed | -$416K | – | 10138 |
|
|
2014
Q4 | $361K | Buy |
+14,905
| New | +$336K | ﹤0.01% | 7825 |
|
Other funds holding PRAH
Jeff Yass's PRAH Position: Q3 2021 in Review
Jeff Yass sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 622,837 shares — an estimated $103M sold.
Jeff Yass first reported a position in PRAH in Q4 2014 and held it in 18 quarters. The position peaked at $103M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Jeff Yass reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Jeff Yass sold 622,837 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $103M.
- Jeff Yass first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 18 quarters.
- Jeff Yass's PRA Health Sciences, Inc. position peaked at $103M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.